A study investigating the IgG glycome in PD showed significant differences between patients and controls, with the authors concluding that the changes observed in PD may result in enhanced Fcγ RIIIa-mediated antibody-dependent cellular cytotoxity (with the potential to contribute to chronic inflammation) (29). Here, FCGR3A is linked to Parkinson disease.